Keywords

Bone cancer

Breast Cancer

General Oncology

Gynecological Cancers

Head and neck cancer

Lung Cancer

Radiation Oncology

Different ways for Drug-Induced Acute urinary organ Cancer

Correspondence to Author: Dr.Gasibova JM 

Department of Pediatrics Azerbaijan Medical University Baku Azerbaijan

Abstract:

Drug-induced predisposition to acute nephrosis (ARF) may be a til now uncharacterized, underappreciated, and tough to observe side of nephrotoxicity that has the potential to own a major human and social impact. Urinary GM2AP was known because the 1st of a replacement category of biomarkers for the inflated risk of acute nephrosis following subnephrotoxic antibiotic treatment in our study. Gentamicin-predisposed animals with no signs of nephritic cancer develop ARF once exposed to a second doubtless toxic drug, that is additionally given at subnephrotoxic doses that square measure safe for nonpredisposed people. Subnephrotoxic antibiotic had no result on nephritic GM2AP organic phenomenon or supermolecule levels, as measured by RT-PCR, Western blot, and immunostaining, and its humor level was unaffected. additional analysis indicates that the upper amount of GM2AP within the piddle is presumably thanks to gentamicin-induced cannular supermolecule mishandling.

Citation:

Dr.Gasibova JM. Different ways for Drug-Induced Acute urinary organ Cancer. World Journal of Medical Oncology 2020.

Journal Info

  • Journal Name: World Journal of Medical Oncology
  • Impact Factor: 2.709**
  • ISSN: 2766-6077
  • DOI: 10.52338/wjoncgy
  • Short Name: WJMOY
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days

INDEXING

  • Crossref indexed journal impact factor of 2.980**
  • Publons indexed journal impact factor of 3.90**
  • Pubmed-indexed journal impact factor of 5.2**
  • International Scientific Indexing (ISI)-indexed journal impact factor of 2.980**
  • Eurasian Scientific Journal Index (ESJI) index journal impact factor of 2.980**
  • Semantic Scholar indexed journal impact factor of 2.980**
  • Cosmos indexed journal impact factor of 3.981**

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility